This project is funded by the European Union
Increasing Prevention and Treatment of TB
This website has been produced with the assistance of the European Union. The content of this website is the sole responsibility of the ILULU partnership and can in no way be taken to reflect the views of the European Union.
Professor Rob Heyderman
Director
Malawi-Liverpool-Wellcome Trust
Clinical Research Programme
Qualifications
PhD FRCP DTM&H
Biography and current role
Rob Heyderman is Professor of Tropical Medicine and Director of the Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW). He trained in London and Zimbabwe, was a Senior Lecturer and then Professor of Infectious Diseases in Bristol before moving to Malawi.
The MLW Clinical Research Programme aims to improve the health of people in Malawi and elsewhere in the Region through excellent research and research training in basic sciences, experimental medicine and public health. Our aim is that MLW will be the Region’s leading laboratory-based health research institution, lead by Malawian and international scientists, inspiring the work of other institutions throughout the World.
Professor Heyderman’s own research interests comprise the biology of severe infection; the development of naturally acquired immunity to bacteria that cause meningitis and pneumonia; regulation of inflammation; and the clinical diagnosis and management of meningitis and other severe infections. Current initiatives include new approaches to mucosal vaccination to prevent pneumonia and meningitis both in the UK and in the tropics; and a trial of steroids in severe sepsis in children.
Role undertaking on the EU TB diagnostics project
Principal investigator
Last updated: 20th May 2008